News
OFF-LABEL DRUGS IN PATHOLOGICAL DEPENDENCIES
OFF-LABEL DRUGS IN PATHOLOGICAL DEPENDENCIES
31 st March 2022 – Aula Vecchioni Policlinico GB Rossi - Verona
Scientific Responsible: Fabio Lugoboni
https://addictus.it/
Pathological dependencies comprise a vast field of clinical situations of varying gravity involving a significant number of patients, with an extremely limited number of drugs quoted in international guidelines.
INEP-Plus - Introduzione alla Evidence-Based Prevention
ISSUP Italy Welcomes New Executive Director
ISSUP Italy would like to announce the resignation of Dr Rosa Giuseppa Frazzica (known as ‘Pina’). Pina was the Executive Director of ISSUP Italy and was instrumental in setting up the National Chapter, which was stemmed during the ISSUP Conference in Brazil in 2016. Pina’s commitment, enthusiasm, dedication to ISSUP Italy has been truly outstanding and on behalf of Casa Rosetta and the entire ISSUP Global team, we wish Pina our very best wishes in the future.
Celebrating the launch of ISSUP Italy
ISSUP Italy Launch
Evolution of SerD intervention between new needs and early approach
Changes in phenomena are now a "mantra" when it comes to harmful consumption and addictions.
Let's talk about Alcohol again. Comparison between professionals on therapeutic pathways and proposals for the future
Although alcohol is the direct and indirect cause of a very high number of deaths every year, and can lead to serious social and mental consequences in those who abuse it, the social attitude towards it maintains alarming spaces of "availability".
Specialist course in addiction and psychiatric pathologies clinic
The training course aims to represent a moment of reflection and in-depth study on the relationship between the different types of disorder from the use of psychoactive substances and psychopathological clinical frameworks. Substance use disorder (SUD) is very common among young patients with schizophrenia. It can precede or follow the onset of psychotic symptoms or the onset of both may coincide. The comorbility of schizophrenia
Current events of DSM 5 on addictions and personality disorders
DSM 5 represented a substantial evolution in the taxonomy of psychiatric pathology and was the product of intense scientific and cultural work that found several moments of great debate, from the abolition of the diagnosis of
HVC training path: activities of SerD and the hospital-territory network
Webinar: HCV elimination plans for substance users: where are we? A focus on evidence